![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 401/12 | |
C07D 401/14 | |||
C07D 405/14 | |||
C07D 413/14 | |||
A61K 31/4439 | |||
A61P 25/00 |
(11) | Number of the document | 2590963 |
(13) | Kind of document | T |
(96) | European patent application number | 11728862.1 |
Date of filing the European patent application | 2011-07-04 | |
(97) | Date of publication of the European application | 2013-05-15 |
(45) | Date of publication and mention of the grant of the patent | 2014-12-03 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2011/061168 |
Date | 2011-07-04 |
(87) | Number | WO 2012/004207 |
Date | 2012-01-12 |
(30) | Number | Date | Country code |
10168688 | 2010-07-07 | EP |
(72) |
NETTEKOVEN, Matthias, DE
RATNI, Hasane, FR
VIFIAN, Walter, CH
|
(73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
(54) | (3-METHYLPYRROLIDIN-3-YL)METHYL PYRIDINYL ETHER DERIVATIVES AND THEIR USE AS NK-3 RECEPTOR ANTAGONISTS |
(3-METHYLPYRROLIDIN-3-YL)METHYL PYRIDINYL ETHER DERIVATIVES AND THEIR USE AS NK-3 RECEPTOR ANTAGONISTS |